Oncaspar

Active Ingredient(s): Pegaspargase
FDA Approved: * February 1, 1994
Pharm Company: * ENZON
Category: Cancer

Pegaspargase, sold under the brand name Oncaspar, is a medication used in the treatment of acute lymphoblastic leukemia (ALL).[2] Often it is used together with anthracycline, vincristine, and prednisone.[3] It is used by injection.[3] Common side effects include allergic reactions, blood clotting problems, high blood sugar, liver problems, pancreas inflammation, and blood clots in the brain.[3] Its use during pregnancy may harm ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Oncaspar 750 [Iu]/Ml Intramuscular; Intravenous Injection, Solution
NDC: 0944-3810
Labeler:
Baxalta Us Inc.
Oncaspar 750 [iu]/Ml Intramuscular; Intravenous Injection, Solution
NDC: 54482-301
Labeler:
Sigma-tau Pharmaceuticals, Inc.
Oncaspar 750 [Iu]/Ml Intramuscular; Intravenous Injection, Solution
NDC: 72694-954
Labeler:
Servier Pharmaceuticals